A Study to Evaluate the Efficacy and Safety of VIB4920 in Participants With Sjögren's Syndrome
Status:
Recruiting
Trial end date:
2023-06-03
Target enrollment:
Participant gender:
Summary
The purpose of the study is to evaluate the efficacy, safety, and tolerability of VIB4920
(formerly MEDI4920) in adult participants with Sjögren's Syndrome (SS).